Sutro Biopharma, Inc 10-Q for FY2025 Q3
Sutro Biopharma, Inc. (STRO)
10-Q
2025-11-06
For: 2025-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on November 6, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $9.69M
- up 13.8% from $8.52M a year earlier
- Net loss
- $56.86M
- compared with a net loss of $48.79M a year earlier
- Diluted EPS
- -$0.67
- compared with -$0.59 a year earlier